Back to Search
Start Over
A Public Option for Clinical Trials? Lessons from Convalescent Plasma.
- Source :
-
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2024; Vol. 52 (1), pp. 98-100. Date of Electronic Publication: 2024 May 31. - Publication Year :
- 2024
-
Abstract
- The case of clinical trials for convalescent plasma during COVID-19 illustrates important lessons for realizing public sector approaches to biomedical research and development. These lessons, centering on mission, transparency, and spillover effects, can be translated to wider efforts to develop a "public option" for clinical trials.
Details
- Language :
- English
- ISSN :
- 1748-720X
- Volume :
- 52
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
- Publication Type :
- Academic Journal
- Accession number :
- 38818610
- Full Text :
- https://doi.org/10.1017/jme.2024.57